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Abstract 
Electrophilic attack of hypochlorous acid on unsaturated bonds of fatty acyl chains is known 
to result mostly in chlorinated products that show cytotoxicity to some cell lines and were 
found in biological systems exposed to HOCl. This study aimed to investigate more deeply 
the products and the mechanism underlying cytotoxicity of phospholipid-HOCl oxidation 
products, synthesized by the reaction of HOCl with 1-stearoyl-2-oleoyl-, 1-stearoyl-2-
linoleoyl-, and 1-stearoyl-2-arachidonyl-phosphatidylcholine. Phospholipid chlorohydrins 
were found to be the most abundant among obtained products.  HOCl-modified lipids were 
cytotoxic towards HUVEC-ST (endothelial cells), leading to a decrease of mitochondrial 
potential and an increase in the number of apoptotic cells. These effects were accompanied by 
an increase of the level of active caspase-3 and caspase-7, while the caspase-3/-7 inhibitor Ac-
DEVD-CHO dramatically decreased the number of apoptotic cells. Phospholipid-HOCl 
oxidation products were shown to affect cell proliferation by a concentration-dependent cell 
cycle arrest in the G0/G1 phase and activating redox sensitive p38 kinase.  The redox 
imbalance observed in HUVEC-ST cells exposed to modified phosphatidylcholines was 
accompanied by an increase in ROS level, and a decrease in glutathione content and 
antioxidant capacity of cell extracts.  
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Introduction 
Programmed cell death is documented to be involved in the initiation and the course of many 
human diseases; for example, endothelial apoptosis and perturbation have been found in 
allograft vasculopathy, hypertension, congestive heart failure, primary pulmonary 
hypertension and sepsis [1]. This process is also thought to contribute in the formation of 
atherosclerotic plaques in the early stages of atherosclerosis [2-4]. Apoptotic endothelial cells 
have been demonstrated to release IL-1 and adhesion molecules, as well as to have reduced 
production of NO and prostacyclins, leading to platelet and neutrophil activation [1]. A 
number of reports have suggested that oxidatively-modified low density lipoproteins (ox-
LDL) are pro-apoptotic factors and can be considered as one of the many risk factors in 
atherosclerosis [5, 6]. In particular, modifications of the protein and lipids of the LDL fraction 
accelerate its uptake by macrophages, resulting in conversion of these cells into foam cells [7, 
8]. Oxidation of LDL components has been attributed to the action of reactive oxygen and 
nitrogen species, released mainly by activated phagocytic cells. However, the presence of 
active myeloperoxidase in the atherosclerotic plaques and the detection of 3-chlorotyrosine 
residues have attracted the attention to the possible role of another oxidant, hypochlorous acid 
(HOCl) [9, 10].  
HOCl generated during the oxidation of Cl- by H2O2 catalysed by myeloperoxidase (MPO), 
mainly inside activated neutrophils, but many data indicate the biological and pathogenic role 
of this enzyme outside phagocytes [11, 12]. The reaction of HOCl with biological molecules 
produces a wide spectrum of oxidized and chlorinated products [13]. The presence of lipid 
and fatty acid chlorohydrins (alpha-chloro, beta-hydroxy derivatives) among the products 
found after red blood cell treatment with HOCl was demonstrated by studies using thin layer 
chromatography (TLC) and antibodies [14]. Jerlich and co-workers used electrospray mass 
spectrometry to identify chlorohydrins of phosphatidylcholines in LDL following oxidation 
with HOCl or the myeloperoxidase system, and found that chlorohydrins are the major 
products formed at low HOCl concentrations [15]. The biological significance and possible 
role of phospholipid chlorohydrins in the pathogenesis of atherosclerosis have been 
demonstrated recently by Messner et al., who showed the presence of lysophosphatidylcholine 
chlorohydrins in atherosclerotic plaques [16]. Recently, fatty acid chlorohydrins have been 
found in plasma (2-4 µM) and white adipose tissue (0.5-4 nmol/mg) with especially high 
levels in ascetic fluid (50-250 µM) during acute pancreatitis [17]. Although the levels of 
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phospholipid chlorohydrins in vivo were not investigated in this study, it is likely that 
correspondingly high levels would also occur in several inflammatory conditions. 
Several studies have reported adverse effects of fatty acid and phospholipid chlorohydrins on 
cells. Early work showed that pre-formed fatty acid chlorohydrins caused lysis of red blood 
cells, which was thought to involve a physical disruption of the membrane [14].  Our recent 
work on this topic has demonstrated that phospholipid chlorohydrins are taken up more 
rapidly than the corresponding unmodified lipids by red blood cells, and incorporated into the 
membrane [18]. Phospholipid chloro- and bromohydrins were found to cause toxicity to 
human umbilical vein endothelial cells (HUVECs), determined by leakage of chromium from 
the cells [19], while in cultured myeloid cells several phospholipid chlorohydrins were 
observed to cause deletion of ATP and loss of viability according to the MTT assay [20]. At 
lower concentrations, production of reactive oxygen species by chlorohydrin-treated 
splenocytes and increased of adherence of splenocytes to chlorohydrin-treated artery 
segments was observed. However, there is some controversy over the mechanism by which 
phospholipid chlorohydrins may cause cell death. Vissers et al. (2001) concluded that the 
mechanism was necrotic, based on a lack of annexin V binding to chlorohydrins-treated 
HUVECs, whereas Deveret al. (2006) reported that chlorohydrins caused an increase in the 
levels of active caspase-3, suggesting that apoptosis occurred at least at certain chlorohydrin 
concentrations [19, 21]. 
The current study was therefore undertaken to investigate in more depth the potential of 
phospholipid-HOCl oxidation products to act as pro-apoptotic and anti-proliferative factors 
for endothelial cells, as this could contribute to the loss of the endothelial monolayer in early 
stages of atherosclerosis. Our study included also the effect of HOCl-modified 
phosphatidylcholines on the intracellular redox state and activation of the key redox sensitive 
kinase p38, which is implicated in many cellular processes (e.g. apoptosis induction and cell 
cycle progression). As mentioned above, phosphatidylcholine chlorohydrins (which are 
demonstrated in the current study and previously published papers [15, 18, 20] as major 
products of the reaction between HOCl and phosphatidylcholines) were shown to induce ROS 
production in splenocytes, thereby acting as less reactive but long-lasting mediators of HOCl 
oxidative action. Immortalized Human Umbilical Vein Endothelial Cells (HUVEC-ST) were 
used as a model cells.1-stearoyl-2-oleoyl-, 1-stearoyl-2-linoleoyl-, and 1-stearoyl-2-
arachidonyl-phosphatidylcholinewere exposed to HOCl as described previously, and the 
products were subjected to more precise analysis (MS/MS and NMR) in order to confirm high 
abundance of lipid chlorohydrins in the mixture of HOCl-modified products [18].  
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Materials and Methods 
Materials: 
Annexin V: FITC Apoptosis Detection Kit I and rabbit, FITC-conjugated anti-caspase-3 
monoclonal antibody were purchased from Becton Dickinson Pharmingen (Warsaw, Poland). 
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), ethidiumbromide, 
ribonuclease-A, hypochlorite, Mitochondria Staining Kit from Sigma Aldrich (Poznań, 
Poland). 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-stearoyl-2-linoleoyl-sn-
glycero-3-phosphocholine (SLPC), 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine 
(SAPC), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-
4-yl) ammonium salt (NBD-phosphatidylethanolamine) and polycarbonate membranes 
(0.1µm) were purchased from Avanti Polar Lipids (Delfzyl, Netherlands), and Sep-Pak® Plus 
C18 cartridges were from Waters (Warsaw, Poland). Dulbecco’s Modified Eagle Medium 
with Glutamax-I, sodium pyruvate and glucose (DMEM), OptiMEM, fetal bovine serum 
(FBS) and penicillin/streptomycin solution were from Invitrogen (Warsaw, Poland), while 
Cell-Based ELISA for p38 phosphorylation from R&D (UK). 
The HUVEC-ST (Human Umbilical Vein Endothelial Cells immortalized by transfection with 
both SV40 large/small T antigens and the catalytic subunit of human telomerase) cell line was 
obtained from Dr. Claudine Kieda (University of Orleans, France), but established and 
characterized at University of Rome Tor Vergata as described by Tentori et al [22]). The cells 
were tested periodically for mycoplasm.  
Synthesis of lipid chlorohydrins 
HOCl-modified phospholipids were synthesized as described in our previous paper [18]. 
Briefly, multilamellar lipid vesicles (10 mg/ml) were obtained by 1 min vortexing of a lipid 
film with Hank’s Buffered Salt Solution, followed by sonication at 37°C for 15 min and a 
further 1 min vortexing. Afterwards, the phospholipid suspension was subjected to HOCl 
treatment at pH 6.0 (5 molar excess of oxidant per one double bond) at 37°C for 30 min. The 
excess HOCl was removed by passing the mixture through a reverse phase Sep-pak cartridges 
and washing with water (use of the Sep-pak cartridges does not significantly alter the 
phospholipid profiles of the preparation and previous work demonstrated that lipid effects 
cannot be attributed to contaminants leaked from the cartridges). Lipids were recovered by 
successive application of methanol, chloroform: methanol (1:1) and chloroform, and organic 
solvents were evaporated under argon. The purification process did not affect composition of 
either unmodified lipids or chlorohydrins. Liposomes added to cell cultures were 
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reconstructed in PBS from the total amount of purified, modified phosphatidylcholines 
(chlorohydrins were not separated from the other oxidation products, which occurred in far 
lower extent). Prior to addition to cell culture, the suspension of liposomes was subjected to 
21 cycles of extrusion (polycarbonate membrane 0.1 µm) in order to obtain unilamellar 
liposomes [23]. As purification of phospholipid-HOCl oxidation products from the excess of 
unbound hypochlorous acid followed by liposome reconstitution from organic solvents may 
result in the loss of lipids, the concentration of phospholipids was quantified each time with 
ammonium ferrithiocyanate [24]. Unmodified, non-purified lipids were used as appropriate 
controls. 
To confirm further the conversion of intact unsaturated lipids into phosphatidylcholine 
chlorohydrins we additionally subjected phospholipid-HOCl oxidation products to MS/MS 
(tandem MS), facilitated by the use of precursor-ion scanning and neutral-loss and 1H-NMR, 
as described in supplementary information.  
The incorporation of liposomes into HUVEC-ST cells was analyzed using NBD-labeled 
liposomes prepared according to a previously described method [18], which were added to 
cells (plated the day before the experiment on a black 96-well plate) and incubated for 
selected time periods. After three cycles of washing with PBS, fluorescence was measured at 
485/538 nm.  
Cell growth and treatment 
HUVEC-ST cells were cultured in OptiMEM supplemented with 2% FBS, 50 U/ml penicillin 
and 50 µg/ml streptomycin (37°C, 5% CO2) [25, 26]. For each experiment, cells were seeded 
24 h before liposome addition at the density of 440 cells/mm2 (which corresponds to 5000 
cells per well on a 96-well plate). The cell density and lipid: cell ratio was the same in all 
experiments. Liposome suspension in PBS was added to the growth medium in which the 
cells were being cultured and immediately mixed gently.  
Determination of cytotoxicity 
The cytotoxicity of unmodified and modified phosphatidylcholines in the culture of HUVEC-
ST cells was estimated on the basis of the DNA content, which corresponds to cell number. 
After 24 h cell incubation with lipids or lipid chlorohydrins on a 96-well black plate, cells 
were washed, lysed, RNA was digested with RNAse and remained DNA was stained with 
propidium iodide as described previously [27].  
Determination of mitochondrial potential 
Mitochondrial potential was estimated using the JC-1-based Mitochondria Staining Kit 
(Sigma Aldrich, Poznań, Poland) according to the manufacturer’s instructions. Fluorescence 
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was measured using a LSR II Flow Cytometer and the ratio between red (FL-2) and green 
(FL-1) fluorescence corresponded to the mitochondrial potential [28]. Valinomycin (0.1 
µg/ml) was used as a positive control for dissipating membrane potential [29].  
Detection of apoptosis and necrosis 
Annexin V: FITC Apoptosis Detection Kit was employed for quantification of the apoptotic 
and necrotic cell population after 6 h cell incubation with liposomes. The procedure of 
staining was carried out according to the instructions provided by the manufacturer. Cell 
fluorescence was analyzed in an LSR II BD Flow Cytometer. Cells emitting weak green and 
weak red fluorescence were classified as living (L), those emitting strong green and weak red 
fluorescence as early apoptotic (EA), cells emitting strong green and strong red as late 
apoptotic (LA), and those emitting weak green and strong red fluorescence as necrotic (N) 
[30, 31].  
To confirm the contribution of caspase-3 and caspase-7 to apoptosis evoked by liposomes, 
cell incubation with liposomes was preceded with a 1 h cell pre-treatment with the caspase-3 
and caspase-7 inhibitor - Ac-DEVD-CHO (10 µM). The presence of the caspase inhibitor 
alone did not affect cell viability (data not shown).  
Determination of caspase-3 and caspase-7 active forms 
After 6 h incubation the cells were trypsinized, fixed with cold 1% formaldehyde in PBS on 
ice for 15 min, permeabilized in 0.1% Tween in PBS at 37°C for 30 min and stained with the 
FITC-conjugated anti-caspase-3 antibody for 1 h. For estimation of active caspase-7 the 
combination of primary anti-caspase-7 (10 µg/ml, 1 h, room temperature) and secondary 
FITC-conjugated antibody (4 µg/ml, 1 h, room temperature) was used. Cells were washed 4 
times with a 10-fold excess of 1% BSA in PBS to remove the excess of unbound antibodies. 
The fluorescence of the cells was read on a LSR II Flow Cytometer at excitation 488 nm, 
emission 530 nm.  
Cell staining with Hoechst 33342 
After 6 h incubation with parent or HOCl-oxidized phosphatidylcholines (100 µM), the cells 
were washed twice with PBS and stained with 10 µM Hoechst 33342 in PBS for 15 min at 
37°C in the dark. Cells were observed using a fluorescence microscope (Olympus IX70, 
Japan; magnification 40×) and were discriminated on the basis of intensity of fluorescence 
and chromatin structure: cells emitting no fluorescence were recognized as living, those 
emitting strong, bright fluorescence and demonstrating condensation of chromatin as early 
apoptotic, cells with bright chromatin distributed to apoptotic bodies as late apoptotic [32, 
33].  
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Analysis of the cell cycle 
The proliferation ability of cells incubated with liposomes for 24 h was estimated on the basis 
on the intracellular DNA content as described previously [27]. The fluorescence of cells 
stained with propidium iodide was read in an LSR II BD Flow Cytometer at excitation 488 
nm and emission 633 nm. Cell distribution in G0/G1, S and G2/M phases was analyzed with 
FlowJo software [34].  
Measurement of reactive oxygen species production 
After 1 h incubation with liposomes, cells were washed three times with PBS and stained with 
5 µM dihydrorhodamine 123 at 37ºC for 30 min. Cell fluorescence was measured in an LSR 
II Becton Dickinson Flow Cytometer at excitation 488 nm/ emission 530 nm. 
The production of superoxide anion by mitochondria was estimated on the basis of MitoSOX 
Red oxidation. Briefly, cells incubated with liposomes for 1 h were washed once with PBS 
and stained with the above-mentioned fluorescent probe (5 µM) at 37 ºC for 15 min. The 
excess of probe was removed in three cycles of cell washing with PBS and cells were 
incubated at 37 ºC for further 30 min. Cell fluorescence was measured in an LSR II Becton 
Dickinson Flow Cytometer at excitation 488 nm/ emission 575 nm. 
Determination of intracellular glutathione  
The intracellular content of glutathione after 1 h cell incubation with liposomes was measured 
with o-phtahalaldehyde as described previously [35]. The glutathione level was normalized to 
protein content determined with the Lowry method. 
Measurement of antioxidant capacity of cell lysates with ABTS cation radical 
Cell lysates obtained after 1 h cell incubation were used for measurement of antioxidant 
capacity (AC) by the ABTS cation radical decolorization assay as described previously [35]. 
The results obtained were standardized to Trolox® and normalized to protein content. 
Measurement of cell lysates antioxidant capacity against HOCl 
For the estimation of the influence of phosphatidylcholine and chlorohydrins on the 
antioxidant capacity of cell lysates against HOCl the Pyrogallol Red based competitive assay 
was employed [36]. In brief, different volumes of cell lysates (prepared in three cycles of 
washing with PBS and centrifugation followed by cell lysis by freezing) were mixed on 96-
well plate with 5 µM Pyrogallol Red solution in 100 mM phosphate buffer (pH = 7.4). 
Addition of HOCl (50 µM) was followed by immediate and vigorous shaking. After 5 min the 
absorbance was read at 540 nm against a reagent blank. The volume providing 50% inhibition 
of Pyrogallol Red oxidation was standardized with respect to ascorbic acid and normalized to 
the protein content. 
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Determination of p38 kinase phosphorylation 
The index of p38 kinase phosphorylation was determined using an ELISA kit (Cell-Based) 
that allows for simultaneous estimation of total p38 protein level as well as the level of its 
phosphorylated form. The determination of p38 and p-p38 was carried out according to the 
instructions provided by the manufacturer after 1.5 h incubation of cells with liposomes. 
Statistical analysis 
The values on the graphs are mean ± SEM. 3-factor analysis of variance (ANOVA) was 
performed using the package STATISTICA to determine which factors (lipid chlorination 
(non-Chloro vs Chloro), fatty acyl composition of the lipids (Lipids), and treatment 
concentration (Conc) affect the data. The detailed outcome of statistical analysis and 
interactions between the factors is included in Supplementary Tables, where the notation 
"Chloro*Lipid*Concentration" relates to the factors above and is used to indicate the 
interaction of 2 or more factors. For example, "P<0.05 Non-chloro vs 
Chloro*Lipid*Concentration" indicates that there was a significant difference between the 
non-chlorinated and chlorinated lipids, and the effect of the chlorination was dependent both 
on lipid type and the concentration. 
Results 
Cytotoxicity of HOCl-oxidized phospahatidylcholines 
Phosphatidylcholines and their modified forms were both found to be cytotoxic towards 
immortalized human umbilical vein endothelial cells employed in this study, although the 
toxicity was significantly greater with chlorinated compared to unmodified lipids. Our 
analysis of HOCl-oxidized phospholipids with MS/MS and 1H-NMR further demonstrated the 
prevailing abundance of phospholipid chlorohydrins among the products of the reaction 
between HOCl and phosphatidylcholines. 1H-NMR spectra demonstrate the loss of vinyl 
protons (CH=CH), allylic protons (CH2C=) and bis-allylic protons (=CCH2C=) in fatty acid 
chains of the phospholipids studied, suggesting complete conversion of parent lipids to HOCl-
modified products (Supplementary Fig. 1). Furthermore, MS/MS analysis revealed neutral 
loss of H35Cl and H37Cl (typical for chlorohydrins [37, 38]) and the presence of chlorohydrin 
dehydration products, while only small amounts of lysolipids were detected (Supplementary 
Fig. 2 and 3). 
Figure 1 shows the effect of liposomes on HUVEC-ST cell number as a percentage of the 
untreated cells, analysed by the DNA content. It can be seen that all factors investigated ( i.e. 
the unsaturated fatty acyl chains in the phosphatidylcholines, their conversion into 
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chlorohydrins, and the concentration administrated to cell culture) significantly affected 
toxicity of lipids (p<0.001 for all factors). The adverse effects of phosphatidylcholine 
liposomes in the culture increased in the sequence as follow: SOPC<SLPC<SAPC, although 
liposomes made of unmodified phosphatidylcholines revealed similar rate and intensity of 
incorporation into cells (Supplementary Fig. 4). Their conversion into chlorinated products 
enhanced significantly cytotoxicity of these compounds, leading to a dramatic reduction in 
cell number after 24 h incubation with SAPC-HOCl liposomes, but only fusion of SLPC-
HOCl and SAPC-HOCl liposomes with HUVEC-ST cells was augmented. 
Phosphatidylcholine-HOCl oxidation products demonstrate pro-apoptotic activity  
The extent of apoptosis in the cells was determined by cell staining with annexin V and 
propidium iodide, followed by analysis of cell fluorescence with flow cytometry (Fig. 1B and 
1C).  Living cells (lower left corner marked with L on PE/FITC dot plots in Fig. 1B), necrotic 
cells (upper left corner, N) and apoptotic cells (the sum of early – EA and late – LA apoptotic 
cells located in lower right and upper right corners, respectively) were counted and presented 
as bars in Fig. 1C. It was found that the effects of lipids conversion into chlorohydrins on the 
extent of apoptosis and loss of cell viability depended on the lipid type and concentration used 
(p<0.001 for Non-chloro vs Chloro*Lipid*Concentration) and all these factors influenced cell 
commitment to apoptosis. Panel 1B demonstrates the increase in the number of annexin V 
positive cells accompanying cell treatment with SAPC and SAPC-HOCl. In contrast to 
programmed cell death, enhancement of cell necrosis resulted from lipids treatment with 
HOCl and from the increase in the concentration used (p<0.05 for Non-chloro vs Chloro and 
p<0.001 for Conc), but irrespectively of lipid type.  
The mitochondrial membrane potential was analyzed using the dye JC-1, and this 
demonstrated dissipation of the mitochondrial electrochemical potential gradient after 6 h 
incubation of HUVEC-ST cells with liposomes made of phosphatidylcholine (Fig 1D). At 
higher doses all the chlorohydrins used caused an increase in the green to red fluorescence 
ratio of JC-1. The intensity of the effects observed depended on the lipid type and its 
concentration, and was enhanced by addition of HOCl molecule(s) to fatty acid chains 
(p<0.01 for all considered factors). Moreover, the differences between native lipids and 
HOCl-modified increased in a concentration-dependent manner (p<0.05 for Non-chloro vs 
Chloro*Conc). A slight drop in mitochondrial potential was also observed in cells incubated 
with liposomes made of unmodified phosphatidylcholines, but only at the highest doses of 
SAPC and SLPC.  
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Cell double staining with Hoechst 33342 additionally confirmed the contribution of apoptosis 
to the reduction of cell number observed on the basis of the DNA staining after 6 h cell 
incubation with liposomes. The course of programmed cell death was accompanied by 
morphological changes of cell nucleus typical for the course of apoptosis: condensation of 
chromatin and formation of apoptotic bodies in HUVEC-ST cells (Fig 1E). HUVEC-ST cells 
exposed to 100 µM SAPC-HOCl for 6 h revealed both early and late apoptotic morphology.  
Caspase-3 and -7 contribute in the course of HOCl-oxidized phosphatidylcholine-
triggered apoptosis 
To obtain further evidence for the occurrence of apoptosis, experiments to measure the level 
of active forms of caspase-3 and caspase-7 with specific antibodies were carried out, and 
demonstrated significant activation of both proteases as a consequence of cell treatment with 
native and phospholipid-HOCl oxidation products (Fig. 2A and 2B). The increase in green 
fluorescence, which corresponded to the level of active caspase-3, as a consequence of lipid 
treatment with HOCl depended also on the lipid type and concentration (p<0.05 for Non-
chloro vs Chloro*Lipid*Conc). Similarly to the results presented above, SLPC and SAPC at 
higher doses were able to increase the intracellular concentration of caspase-3, but the level of 
this enzyme was lower when compared to cells treated with the corresponding HOCl-treated 
lipid (p<0.001 for Non-chloro vs Chloro). Similarly, activation of caspase-7 was enhanced in 
response to lipid oxidation with HOCl and the increase in concentration of lipids, but also 
lipid composition affected caspase-7 processing (p<0.001 for Non-chloro vs Chloro, Conc 
and Lipid). 
The use of caspase-3/-7 inhibitor Ac-DEVD-CHO at the final concentration of 5 µM 
effectively inhibited apoptosis initiated by parent and modified phosphatidylcholine liposome 
in HUVEC-ST cells, as determined using flow cytometry after cell staining with annexin V 
and propidium iodide (Fig. 2C), indicating the crucial role of these executioner proteases in 
the cells studied.   
Phosphatidylcholine modified by HOCl affects cell cycle progression 
HOCl-oxidized phosphatidylcholines at the concentration of 50 µM affected division of 
HUVEC-ST cells (Fig. 3). Analysis of the cell cycle demonstrated a statistically significant 
increase in the number of cells in G0/G1 phase after 24 h cell exposure to all chlorinated lipids 
used in the study. Partial cell arrest in the G0/G1 phase was followed by the reduction of cell 
populations in S and G2/M phase. As in the experiments described above, the extent of the 
growth inhibition was strongly dependent on the type of lipid analyzed, concentration used 
and lipid treatment with HOCl (p<0.05 for all). The above-mentioned factors influenced cell 
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distribution in G0/G1, S and G2/M phase and were dependent on each other (p<0.05 for Non-
chloro vs Chloro*Lipids*Conc in all cell cycle phases).  
Redox imbalance and activation of p38 kinase as consequences of HOCl-oxidized 
phosphatidylcholine action on HUVEC-ST cells 
An increased level of reactive oxygen species accompanied by the drop of glutathione content 
and antioxidant capacity was found after 1 h HUVEC-ST cell incubation with liposomes 
made of phospholipid-HOCl oxidation products (Fig. 4). Augmented ROS production 
estimated with dihydrorhodamine 123 was observed as a consequence of lipid conversion into 
HOCl-oxidized products, and differed significantly between concentrations and composition 
of lipids (p<0.001 for all factors) (Fig. 4A). Similar pattern of changes was also found for the 
oxidation of MitoSOX Red probe, which undergoes oxidation upon reaction with superoxide 
anion released by mitochondria (Fig. 4B); therefore mitochondria can be considered as a 
significant contributor to ROS generation observed upon cell treatment with HOCl-modified 
lipids. ROS release from mitochondria was significantly affected by modification of parent 
lipids with HOCl as well as by lipid type and concentrations used in our study (p<0.001 for all 
factors separately and for Non-chloro vs Chloro*Lipid*Conc). All these factors influenced 
also intracellular concentration of glutathione, antioxidant capacity of cell lysates and 
phosphorylation of p38 kinase.  The first of these parameters decreased most dramatically 
after 1 h incubation of cells with SAPC-HOCl (to ~39% for 100 µM SAPC-HOCl, when 
compared to untreated control) (Fig. 4E). Also unmodified phosphatidylcholines caused 
reduction in the GSH content of HUVEC-ST cells, but the extent of changes observed was 
smaller than in cells treated with HOCl-modified form of lipids (p<0.001 for Non-chloro vs 
Chloro). The lysates of cells incubated for 1 h with HOCl-modified lipids, but also with their 
native forms, demonstrated reduced antioxidant capacity (Fig. 4C and 4D). Cell treatment 
with the above-mentioned compounds decreased significantly the ABTS cation radical 
scavenging ability of cell lysates, as well as the ability to protect Pyrogallol Red against 
HOCl-induced oxidation in a lipid, concentration and chlorination-dependent manner.  
To investigate the possible involvement of HOCl oxidized phospholipids on cellular 
signaling, we estimated the phosphorylation of p38 kinase, as this is a known redox sensitive 
kinase and contributes to a signaling process leading to apoptosis. A 1.5 h cell incubation with 
modified phosphatidylcholines was found to cause activation of p38 kinase (Fig. 4F). An 
increased index of phosphorylation (p-p38/p38) was found in HUVEC-ST cells exposed to 
both unmodified and HOCl-modified phosphatidylcholines, but the enhancement of effects 
resulting from lipid conversion into the HOCl-modified form depended on the lipid structure 
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and concentration administrated to cell culture (p<0.001 for all factors separately and for 
Non-chloro vs Chloro*Lipid*Conc). 
 
Discussion 
A possible role for HOCl-modified lipids in pathogenesis of atherosclerosis has been 
suggested by the demonstration that they occur in atherosclerotic lesions, cause increased 
leukocyte-endothelial adhesion in arterial segments, and may also contribute to formation of 
the necrotic core of atherosclerotic lesions owing to their toxicity [16, 39, 40]. However, 
questions about the mechanism of toxicity to cells remain. Here, we confirmed the toxicity of 
liposomes made of phospahtidylcholine-HOCl oxidation products to HUVEC-ST cells 
(immortalized endothelial cells), demonstrating that cell treatment with modified lipids for 24 
h reduced cell number compared to untreated controls by the induction of programmed cell 
death and growth arrest. Using 3-factor Anova we also demonstrate that lipid-oxidation 
dependent enhancement in cell commitment to apoptosis as well in accumulation of cells in 
G0/G1 phase is affected by lipid type and concentration used (all these factors influenced each 
other in both experiments, p<0.05 for Non-chloro vs Chloro*Lipid*Conc). As we showed in 
previously published papers [18, 37, 38], and confirmed in the present study, hypochlorous 
acid attacked double bonds leading to addition of –Cl and –OH to two adjacent carbons in 
fatty acid chains and formation of the corresponding chlorohydrins. Because the other 
products of phosphatidylcholines oxidation with HOCl and lysolipids occurred at much lower 
concentration, chlorohydrins are considered as mediators of HOCl action in cellular systems.  
Previously, there had been conflicting reports on the mechanisms of cell death brought about 
by lipid or fatty acid chlorohydrins [19, 21].  Although Vissers et al. used the same method as 
in our study (annexin V/propidium iodide double-staining), they did not observe any increase 
in the number of early apoptotic cells (annexin V positive, propidium iodide negative) after 
HUVEC treatment with 100 µM oleic acid chlorohydrin for 90 min. Moreover, they did not 
report the formation of double-positive population of cells as we did, and most of the cells 
showed only red fluorescence, leading to the conclusion that there was direct necrosis, 
accompanied by cell lysis. A possible explanation could be different approaches to 
identification of apoptotic cells after annexin V/propidium iodide staining. In this study, we 
distinguished between apoptotic (all annexin V positive cells) and necrotic (propidium iodide 
positive/annexin V negative cells) populations, while Vissers et al. considered all red 
fluorescent cells (also double-stained) as necrotic. Even using their criteria for apoptosis we 
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still obtain a statistically significant increase in the number of early apoptotic cells (4.97 ± 
0.67%, 8.35 ± 1.37%, and 13.65 ± 3.85% for SOPC-HOCl, SOPC-HOCl and SAPC-HOCl, 
respectively). The occurrence of necrosis according to Vissers et al. was attributed to 
disruption of the plasma membrane owing to incorporation of fatty acid chlorohydrins, which 
have a more polar and bulky nature than native phospholipids. It has also been shown that 
conversion of unsaturated phospholipids into chlorohydrins results in a stronger incorporation 
of liposomes into red blood cells, an increase of lipid order, decrease of permeability of the 
lipid bilayer in liposomes [18]. A later study reported that SOPC chlorohydrin induced 
apoptosis of U937 monocytic cells with the activation of caspase-3 [21]. In the current study, 
increase in the intensity of programmed cell death in response to phosphatidylcholine 
conversion into HOCl-modified analogs was evident in the HUVEC-ST cells after 6 h 
incubation with lipids; they showed classical, frequently described features of apoptosis, 
including dissipation of the mitochondrial membrane potential, externalization of 
phosphatidylserine, activation of caspase-3 and caspase-7, chromatin condensation and 
formation of apoptotic bodies. Notably, all these pro-apoptotic and pro-necrotic effects were 
found after cell incubation with pathophysiological concentrations of HOCl-oxidized 
phospholipids. The highest concentration used in our study did not exceed 100 µM 
(significant cellular disorders were caused by far lower doses, around 10 µM for SAPC-
HOCl), while acute pancreatitis triggered in a mouse model was accompanied by generation 
of chlorohydrin reaching a concentration of 250 µM in ascitic fluid [17]. 
The liposomes made of SLPC-HOCl and SAPC-HOCl were demonstrated to incorporate to a 
far higher extent than parent phosphatidylcholines, while SOPC, SLPC, SAPC and SOPC-
HOCl revealed a similar rate and intensity of fusion with HUVEC cells, but the toxicity 
differed significantly between all lipid types, as well as between HOCl-treated and untreated 
phosphatidylcholines. Thus, the biophysical parameters of liposome bilayer seem to have 
limited impact on cell apoptosis and the effects of fatty acid chlorohydrins may differ from 
phospholipid chlorohydrins. In the model we studied, increased cytotoxicity resulting from 
phosphatidylcholine oxidation with HOCl was also significantly influenced by the type of 
lipid (Fig. 1A, p<0.001 for Non-chloro vs Chloro*Lipid). Therefore, the observed effects 
seem to depend on the number of HOCl molecules added to phosphatidylcholine fatty acid 
chains. It is also important to bear in mind that SAPC-HOCl, which had the highest activity, 
also contained the highest proportion of lysolipids (up to ~10%). Cytotoxicity of lysolipids 
has been reported previously, although it was also found that they did not affect membrane 
asymmetry and could not contribute to observed externalization of phosphatidylserine [41]. In 
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terms of cell membrane localization of HOCl-modified lipids, the structure of the lipid 
molecule is likely to be of crucial importance as it may affect the local membrane 
environment. As we demonstrated previously, an increase in level of chlorination was 
accompanied by an increase in liposome membrane rigidity and erythrocyte lysis [18]. Such 
alterations in cellular membrane structure or intracellular membranes may impair or trigger 
signaling pathways and intracellular events, e.g. apoptosis. 
 The key role of caspase-3 and caspase-7 in the course of apoptosis induced by 
phosphatidylcholines-HOCl oxidation products was indicated by the observation that pre-
incubation of the cells with a caspase-3/-7 inhibitor (Ac-DEVD-CHO) effectively protected 
them against programmed death. We found a concentration, lipid and chlorination-dependent 
increase in cell fluorescence corresponding to the intracellular concentration of the active 
caspase-3 and caspase-7 after 6 h of incubation, reaching the highest value for 100 µM SAPC-
HOCl treated cells. This initially does not appear to agree with the hypothesis of 
concentration-dependent mode of cell death suggested previously [21], whereby lower doses 
of chlorohydrins were thought to induce apoptosis and higher doses caused necrosis. 
However, in the study by Dever et al., cells were treated with HOCl-modified SOPC and 
SAPC for 24 hrs, which may have allowed the cells to progress further towards a secondary 
necrosis, and could account for the effects observed [21]. 
After 6 h incubation we observed augmented decline in the mitochondrial membrane potential 
in a consequence of cell treatment with HOCl-modified phosphatidylcholines when compared 
to parent lipids, which was also dependent on the concentration and type of lipid. It is difficult 
to speculate on the mechanism underlying the loss of mitochondria function as sufficient and 
convincing data have not been published yet, but the possibility of oxidized lipid interaction 
and incorporation into mitochondria membrane should be taken into consideration, as a study 
on the fluorescently labeled electrophilic lipid 15d-PGJ2 showed strong colocalization with 
mitochondria and enhanced generation of reactive oxygen species from these organelles in 
endothelial cells [42]. Furthermore, the oxidized phospholipid PazePC was documented to 
increase membrane-association of pro-apoptotic Bax protein, which triggers outer membrane 
permeabilization [43]. The HOCl-modified phosphatidylcholines studied here led to a 
relatively rapid increase in ROS generation by mitochondria (observed after 1 h cell treatment 
with liposomes), followed by a decline in mitochondria membrane potential comparied to the 
corresponding native lipids. Therefore, the possible oxidized lipid cross-talk with 
mitochondria may involve many mechanisms. The dissipation of the mitochondrial membrane 
potential is usually followed by the release of pro-apoptotic factors, occurring thus as an early 
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event of apoptosis leading to activation of effector caspases [44]. Also in case of HOCl-
modified phosphatidylcholines, the loss of mitochondria membrane potential was followed by 
activation of caspase-3 and caspase-7 and externalization of phosphatidylserine. Bearing in 
mind the rapid production of reactive oxygen species by mitochondria upon treatment with 
HOCl-PC, these organelles seem to play a key role in apoptosis induction in our cellular 
model, although the external, cell membrane-associated signaling routes cannot be excluded. 
These findings suggest that phospholipid-HOCl oxidation products may act also as signaling 
molecules affecting cell regulatory pathways. Our experiments further demonstrated 
activation of p38 kinase as a result of relatively short exposure of HUVEC-ST cells to HOCl-
modified phosphatidylcholine, significantly stronger than that with non-oxidized lipids. This 
enzyme, phosphorylated under different types of stress e.g. excessive ROS production, was 
documented to undergo activation also in cells subjected to the action of LDL and oxLDL 
[45, 46]. When phosphorylated, p38 kinase may contribute to e.g. apoptosis induction, 
inhibition of cell proliferation, and pro-inflamatory cytokine release. 
Some data have indicated the possibility of p53-dependent apoptosis induced by oxidatively 
modified LDL due to the release of reactive oxygen species (ROS) by disrupted mitochondria 
[6]. Thus, the mechanism underlying the triggering of apoptosis in cells by HOCl-modified 
phosphatidylcholines may be similar to that found for oxLDL. Our results confirmed the 
enhanced indirect pro-oxidative properties of phosphatidylcholines upon their treatment with 
HOCl in the culture of HUVEC-ST cells. When added to cell culture, these compounds 
caused a decrease in GSH content, accompanied by reduced antioxidant capacity of cell 
extracts and elevated ROS level, which seem to result mostly from impaired mitochondria, as 
shown with the MitoSOX Red fluorescent probe. Moreover, these compounds have not yet 
been found to be reactive or oxidize/chlorinate other biological molecules, which limits the 
possibility of their direct action on the activity of ROS-producing enzymes. Although some 
data in the literature point at possible covalent as well as non-covalent interaction of lipids 
with proteins [47, 48], these findings concern mostly interactions between lipid aldehydes 
with nucleophilic centers and α-β unsaturated carbonyls with thiolate groups. 
OxLDL has been found to inhibit the proliferation of endothelial cells, in contrast to its 
growth-promoting effects on smooth muscle cells (SMCs) and monocyte-macrophages, 
although the mechanism involved was not elucidated [49]. Here, we have shown that in 
addition to causing apoptosis, phosphatidylcholines modified by HOCl were found to affect 
the proliferation ability of cultured cells, arresting them in G0/G1 phase. Thus our study has 
shown that phospholipid-HOCl oxidized products have effects that could account for the 
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oxLDL-induced apoptosis and inhibition of proliferation observed previously, but further 
experiments are necessary to confirm their role. 
In summary, our data clearly indicate that HOCl-oxidized phosphatidylcholines at 
pathophysiologically relevant concentrations have complex cellular effects, significantly 
stronger than corresponding non-modified lipids. All methods utilized in this study support 
the conclusion that our modified lipids trigger apoptosis in immortalized endothelial cells in 
addition to other cellular disturbances such as redox imbalance and proliferation impairment 
in a lipid and concentration-dependent manner. Therefore, the pro-apoptotic properties of 
these molecules may contribute to the induction or/and progression of atherosclerosis or other 
inflammatory conditions where HOCl-modified lipids are likely to occur.  
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Figure legends 
 
Figure 1. Phosphatidylcholine modified by HOCl triggers apoptosis in cultured 
HUVEC-ST cells. 
(A) The cytotoxicity of liposomes made of native and modified phosphatidylcholines after 24 
h cell incubation was estimated on the basis of the DNA quantity which corresponds to cell 
number. (B and C) The flow cytometry analysis of cells double stained with annexin V and 
propidium iodide was employed for the estimation of pro-apoptotic properties of liposomes 
added to the growth medium for 6 h. (B) Annexin V positive cells were assumed as apoptotic 
(EA + LA), propidium iodide (PI) positive as necrotic (N),  while double negative cells as 
living (L). Dissipation of mitochondrial potential (D) in cells exposed to wide range of HOCl-
modified and intact phospholipids concentration for 6 h was observed on the basis of cell 
double staining with JC-1/PI, while the alteration of chromatin structure (E) in cells incubated 
with SAPC-HOCl for 6 h after cell staining with Hoechst 33342. Dark cells exhibiting no 
fluorescence were assumed as living, brightly fluorescent with chromatin condensed as early 
apoptotic, while cells with chromatin distributed to apoptotic bodies were assumed as late 
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apoptotic. Results are presented as mean ± SEM. ANOVA (3-factor): Significant effects for 
panel (A): Non-chloro vs Chloro F=352.8 (p<0.001), Lipids F=53.0 (p<0.001), Conc F=99.8 
(p<0.001), Fisher’s PLSD = 11.87; for panel (C): LIVING; Non-chloro vs Chloro F=91.9 
(p<0.001), Lipids F=34.9 (p<0.001), Conc F=171 (p<0.001), Fisher’s PLSD = 3.67; 
significant effects for APOPTOSIS; Non-chloro vs Chloro F=56.2 (p<0.001), Lipids F=27.2 
(p<0.001), Conc F=112 (p<0.001), Fisher’s PLSD = 3.92; significant effects for NECROSIS; 
Non-chloro vs Chloro F=4.71 (p<0.05), Conc F=16.58 (p<0.001), Fisher’s PLSD = 2.26; for 
panel (D): Non-chloro vs Chloro F=30.9 (p<0.001), Lipids F=7.02 (p<0.01), Conc F=39.3 
(p<0.001), Fisher’s PLSD = 0.03.  
 
Figure 2. HOCl-oxidized phosphatidylcholine-triggered apoptosis proceeds with the 
involvement of executioner caspases: caspase-3 and caspase-7 
The intracellular level of the active form of caspase-3 (A) and caspase-7 (B) in cells exposed 
to the action of native phospholipids and phospholipid-HOCl oxidation products for 6 h was 
evaluated using the combination of immunostaining and flow cytometry. (C) Cell incubation 
with liposomes (6 h) was preceded with 1 h cell treatment with the inhibitor of executioner 
caspase-3/-7 (Ac-DEVD-CHO). Subsequently, cells were stained and analyzed as showed in 
Figure 1B. ANOVA (3-factor): Significant effects for panel (A): Non-chloro vs Chloro 
F=45.9 (p<0.001), Lipids F=31.0 (p<0.001), Conc F=74.1 (p<0.001), Fisher’s PLSD = 27.8; 
for panel (B): Non-chloro vs Chloro F=19.0 (p<0.001), Lipids F=54.6 (p<0.001), Conc 
F=98.3 (p<0.001), Fisher’s PLSD = 15.7 
 
Figure 3. Products of phosphatidylcholines oxidation by HOCl affect proliferation of 
HUVEC-ST cells 
Cell cycle was examined after 24 h cell incubation with liposomes made of parent 
phospholipids and modified by HOCl (50 µM) on the basis of DNA content in single cells. 
Cells were permeabilized, stained with propidium iodide and analyzed by flow cytometry. 
Bars on the figure present the mean ± SEM. ANOVA (3-factor): Significant effects for G0/G1: 
Non-chloro vs Chloro F=82.9 (p<0.001), Lipids F=17.5 (p<0.001), Conc F=105.4 (p<0.001), 
Fisher’s PLSD = 4.46; S: Non-chloro vs Chloro F=24.2 (p<0.001), Lipids F=6.06 (p<0.05), 
Conc F=625.1 (p<0.001), Fisher’s PLSD = 4.78; G2/M: Non-chloro vs Chloro F=47.1 
(p<0.001), Lipids F=7.99 (p<0.01), Conc F=77.2 (p<0.001), Fisher’s PLSD = 2.48. 
 
21 
 
Figure 4. Exposure of HUVEC-ST cells to phosphatidylcholine modified by HOCl 
results in redox imbalance 
Generation of reactive oxygen species (A) inside cells subjected to the action of liposomes for 
1 h was studied using dihydrorhodamine 123 staining, while release of superoxide anion from 
mitochondria (B) with MitoSOX Red. Protection of Pyrogallol Red against HOCl-induced 
oxidation was measured in cell lysates collected after 1 h cell incubation with liposomes (C), 
while antioxidant capacity (AC) was estimated on the basis of ABTS cation radical 
decolorization (D). Concentration of glutathione (E) was measured spectrofluorometrically 
after derivatization with o-phtalaldehyde. The phophorylation index of p38 kinase was 
determined using cell based ELISA method in cells incubated for 1.5 h with chlorohydrins 
and unmodified lipids (F). Bars on the figure present the mean ± SEM. ANOVA (3-factor): 
Significant effects for panel (A): Non-chloro vs Chloro F=84.4 (p<0.001), Lipids F=18.2 
(p<0.001), Conc F=43.5 (p<0.001), Fisher’s PLSD = 10.2; for panel (B): Non-chloro vs 
Chloro F=382.3 (p<0.001), Lipids F=145.3 (p<0.001), Conc F=326.8 (p<0.001), Fisher’s 
PLSD = 3.48; for panel (C): Non-chloro vs Chloro F=6.15 (p<0.05), Lipids F=3.67 (p<0.05), 
Conc F=25.2 (p<0.001), Fisher’s PLSD = 12.6; for panel (D): Non-chloro vs Chloro F=5.41 
(p<0.05), Lipids F=11.7 (p<0.01), Conc F=93.7 (p<0.001), Fisher’s PLSD = 3.54; for panel 
(E): Non-chloro vs Chloro F=109.9 (p<0.001), Lipids F=44.5 (p<0.001), Conc F=63.9 
(p<0.001), Fisher’s PLSD = 1.00; for panel (F): Non-chloro vs Chloro F=22.7 (p<0.001), 
Lipids F=28.3 (p<0.001), Conc F=51.3 (p<0.001), Fisher’s PLSD = 0.07. 
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Supporting Figure 1. 1H-NMR spectra showing the formation of chlorohydrins from SOPC (a), SLPC
(b) and SAPC (c). In each panel, native lipid is the bottom, red spectrum and chlorohydrin is the top,
blue spectrum. In the native spectra, the multiplet labelled (1) at 5.3 ppm corresponds to the vinyl
protons (CH=CH), the multiplet (2) at 2.8 ppm is bis-allylic protons (=CCH2C=) which is absent in
SOPC, and the multiplet (3) corresponds to allylic protons (CH2C=). These signals all disappear on
formation of chlorohydrins indicating the loss of the double bonds, and other signals corresponding to
CHs and CH2s adjacent to the substituted carbons appear (4 & 5). Phospholipids were prepared in
1:1:2:10 pyridine-d5: DCl in D2O: methanol-d4: chloroform-d; spectra were acquired at 270 MHz and
referenced to tetramethylsilane at 0 ppm.
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Supporting Figure 2. MSMS data for phospholipid chlorohydrins showing characterization by neutral loss (NL) of 36 and 38 Da,
corresponding to loss of H35Cl and H37Cl respectively. Panels A & B show SOPC mono-chlorohydrin at m/z 840 and 842
respectively for the HO35Cl and HO37Cl products. Panels C & D show SLPC chlorohydrins with the bis-chlorohydrins at m/z 890 and
892. Panels E & F show multiple SAPC chlorohydrins, although the tetra-chlorohydrin cannot be observed as the top instrument m/z
is 1000. All chlorohydrin show the presence of dehydration products under the fragmentation conditions used, as described
previously (Pitt and Spickett, 2008, Biochem Soc Trans). No significant formation of lysolipids was observed with SOPC and SLPC,
but a small amount (~10%) of lysolipid at m/z 524 did occur. MS analysis was carried out using direct infusion onto an ABSciex
5500QTrap, essentially as described previously (Spickett et al., 2011, FRBM).
Supporting Figure 3. MSMS fragmentation profile of
SOPC mono-chlorohydrin at m/z 840 (A) and SLPC bis-
chlorohydrin at m/z 890 (B). SOPC chlorohydrin shows
SOPC ClOH
EPI 840
(A)
fragment ions at m/z 524 and 506, corresponding to the
lysolipid retaining stearate, and peaks at m/z 574 and
556 for lysolipid retaining the chlorohydrin modified
chain. SLPC chlorohydrin shows the same fragment ions
for the lysolipid retaining stearate, and peaks at m/z 624
and 606 for lysolipid retaining the bis-chlorohydrin
modified chain. Both parent ions also show characteristic
loss of water (18 Da) and HCl (36 Da). MS analysis was
carried out using direct infusion onto an ABSciex
5500QTrap, essentially as described previously (Spickett
et al., 2011, FRBM).
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Supporting Figure 4. Incorporation of liposomes to HUVEC-ST cells
The fusion of liposomes labeled with NBD with cells was determined on the basis of cell
fluorescence measurement at selected incubation points. Each result shows mean ± SEM, n=3.
Significant effects: Non-chloro vs Chloro F=46.8 (p<0.001), Lipids F=10.56 (p<0.001), Time
F=5.40 (p<0.01), Fisher’s PLSD = 0.0014
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Suppl. Table 1A. Statistical analysis for Fig. 1A (cytotoxicity of 
Non-chloro & Chloro lipids)
DF MS F p
Intercept 1 1321379 11959.43 0.000000
NC/C 1 38976 352.76 0.000000
Lipids 2 5850 52.95 0.000000
Conc 5 11032 99.84 0.000000
NC/C*Lipids 2 2967 26.85 0.000000
NC/C*Conc 5 3007 27.21 0.000000
Lipids*Conc 10 294 2.66 0.004653
NC/C*Lipids*Conc 10 138 1.25 0.262618
Error 180 110
Suppl. Table 1B. Statistical analysis for Fig. 1C (Flow cytometry
analysis of Living cells at 24 hr)
DF MS F p
Intercept 1 579257 86031 0.000000
NC/C 1 618.5 91.85 0.000000
Lipids 2 235.2 34.94 0.000000
Conc 2 1156.2 171.72 0.000000
NC/C*Lipids 2 100.7 14.95 0.000007
NC/C*Conc 2 240.5 35.71 0.000000
Lipids*Conc 4 89.7 13.32 0.000000
NC/C*Lipids*Conc 4 35.6 5.28 0.001153
Error 54 6.7
Suppl. Table 1C. Statistical analysis for Fig. 1C (Flow cytometry
analysis of Apoptosis at 24 hr)
DF MS F p
Intercept 1 4532.8 594.66 0.000000
NC/C 1 428.61 56.23 0.000000
Lipids 2 207.54 27.23 0.000000
Suppl. Table 1D. Statistical analysis for Fig. 1C (Flow cytometry
analysis of Necrosis at 24 hr)
DF MS F p
Intercept 1 423.352 166.871 0.000000
NC/C 1 11.948 4.709 0.034415
Lipids 2 0.071 0.028 0.972432
Supplementary Tables. Statistical analysis by 3-factor ANOVA for all the figures. Univariate tests of 
Significance for Data Vial (prz1) Sigma-restricted parameterization with effective hypothesis decomposition. 
DF = Degrees of freedom; MS = Mean squares; F = Fisher ratio (treatment variance/baseline variance); p = 
probability.
Conc 2 858.78 112.66 0.000000
NC/C*Lipids 2 81.89 10.74 0.000118
NC/C*Conc 2 152.43 19.99 0.000000
Lipids*Conc 4 71.81 9.42 0.000008
NC/C*Lipids*Conc 4 28.12 3.69 0.009980
Error 54 7.62
Conc 2 42.059 16.578 0.000002
NC/C*Lipids 2 3.423 1.349 0.268028
NC/C*Conc 2 6.680 2.633 0.081062
Lipids*Conc 4 0.185 0.073 0.990076
NC/C*Lipids*Conc 4 2.247 0.886 0.478692
Error 54 2.537
Suppl. Table 1E. Statistical analysis for Fig. 1D (mitochondrial 
potential)
DF MS F p
Intercept 1 153.327 9911.68 0.000000
NC/C 1 0.479 30.937 0.000000
Lipids 2 0.109 7.024 0.001214
Conc 4 0.608 39.281 0.000000
NC/C*Lipids 2 0.043 2.804 0.063773
NC/C*Conc 4 0.042 2.692 0.033252
Lipids*Conc 8 0.021 1.355 0.220972
NC/C*Lipids*Conc 8 0.006 0.409 0.914148
Error 150 0.016
Suppl. Table 2A. Statistical analysis for Fig. 2A (Caspase-3 
activity at 6 hr)
DF F p
Intercept 1 878217.3 3158.11 0.000000
NC/C 1 12775.9 45.94 0.000000
Lipids 2 8622.0 31.01 0.000000
Conc 2 20619.5 74.15 0.000000
NC/C*Lipids 2 2247.4 8.08 0.001261
NC/C*Conc 2 5816.9 20.92 0.000001
Lipids*Conc 4 3518.9 12.65 0.000002
NC/C*Lipids*Conc 4 744.4 2.68 0.047240
Error 36 278.1
Suppl. Table 2B. Statistical analysis for Fig. 2B (Caspase-7 
activity at 6 hr) 
DF MS F p
Intercept 1 484764.5 8681.90 0.000000
NC/C 1 1060.2 18.99 0.000379
Lipids 2 3045.7 54.55 0.000000
Conc 2 5486.0 98.25 0.000000
NC/C*Lipids 2 404.5 7.24 0.004919
NC/C*Conc 2 1021.7 18.30 0.000046
Lipids*Conc 4 1054.5 18.89 0.000003
NC/C*Lipids*Conc 4 146.4 2.62 0.069229
Error 18 55.8
Suppl. Table 3A. Statistical analysis for Fig. 3 (% of cells in 
G0/G1 phase)
DF MS F p
Intercept 1 65798.6 15751.9 0.000000
NC/C 1 346.2 82.9 0.000001
Lipids 2 73.3 17.5 0.000274
Conc 1 440.4 105.4 0.000000
Suppl. Table 3B. Statistical analysis for Fig. 3 (% of cells in S 
phase)
DF MS F p
Intercept 1 23495.3 4882.07 0.000000
NC/C 1 116.66 24.24 0.000352
Lipids 2 29.15 6.06 0.015193
Conc 1 120.97 25.14 0.000302
NC/C*Lipids 2 51.1 12.2 0.001271
NC/C*Conc 1 346.2 82.9 0.000001
Lipids*Conc 2 73.3 17.5 0.000274
NC/C*Lipids*Conc 2 51.1 12.2 0.001271
Error 12 4.2
NC/C*Lipids 2 20.01 4.16 0.042460
NC/C*Conc 1 116.66 24.24 0.000352
Lipids*Conc 2 29.15 6.06 0.015193
NC/C*Lipids*Conc 2 20.01 4.16 0.042460
Error 12 4.81
Suppl. Table 3C. Statistical analysis for Fig. 3 (% of cells in 
G2/M phase)
DF MS F p
Intercept 1 6416.57 4963.75 0.000000
NC/C 1 60.93 47.14 0.000017
Lipids 2 10.33 7.99 0.006226
Conc 1 99.74 77.16 0.000001
NC/C*Lipids 2 7.30 5.65 0.018674
NC/C*Conc 1 60.93 47.14 0.000017
Lipids*Conc 2 10.33 7.99 0.006226
NC/C*Lipids*Conc 2 7.30 5.65 0.018674
Error 12 1.29
Suppl. Table 4A. Statistical analysis for Fig. 4A (Cellular ROS 
production measured by dihydrorhodamine 123)
DF MS F p
Intercept 1 595766.3 2810.5 0.000000
NC/C 1 17899.7 84.4 0.000000
Lipids 2 3850.1 18.2 0.000048
Conc 2 9229.8 43.5 0.000000
NC/C*Lipids 2 1721.6 8.1 0.003064
NC/C*Conc 2 5926.4 27.9 0.000003
Lipids*Conc 4 1170.1 5.5 0.004428
NC/C*Lipids*Conc 4 499.0 2.4 0.092756
Error 18 212.0
Suppl. Table 4B. Statistical analysis for Fig. 4B (Mitochondrial 
ROS production measured by MitoSOX red)
DF MS F p
Intercept 1 862992 16425.5 0.000000
NC/C 1 20087.8 382.3 0.000000
Lipids 2 7632.6 145.3 0.000000
Conc 2 17170.2 326.8 0.000000
NC/C*Lipids 2 4587.6 87.3 0.000000
NC/C*Conc 2 5370.8 102.2 0.000000
Lipids*Conc 4 2100.4 39.9 0.000000
NC/C*Lipids*Conc 4 1212.8 23.1 0.000000
Error 36 52.5
Suppl. Table 4C. Statistical analysis for Fig. 4C (Protection of 
pyrogallol red in cell lysates)
DF MS F p
Intercept 1 903558.5 2026.959 0.000000
NC/C 1 2740.3 6.147 0.020575
Suppl. Table 4D. Statistical analysis for Fig. 4D (Antioxidant 
capacity of cell lysates by ABTS decolorization)
DF MS F p
Intercept 1 158687.3 10052.51 0.000000
NC/C 1 85.4 5.41 0.038341
Lipids 2 1635.3 3.668 0.040727
Conc 1 11245.1 25.226 0.000039
NC/C*Lipids 2 13.2 0.030 0.970904
NC/C*Conc 1 2740.3 6.147 0.020575
Lipids*Conc 2 1635.3 3.668 0.040727
NC/C*Lipids*Conc 2 13.2 0.030 0.970904
Error 24 445.8
Lipids 2 184.7 11.70 0.001517
Conc 1 1479.3 93.71 0.000001
NC/C*Lipids 2 47.4 3.01 0.087456
NC/C*Conc 1 85.4 5.41 0.038341
Lipids*Conc 2 184.7 11.70 0.001517
NC/C*Lipids*Conc 2 47.4 3.01 0.087456
Error 12 15.8
Suppl. Table 4E. Statistical analysis for Fig. 4E (Glutathione 
concentration in cell lysates)
DF MS F p
Intercept 1 164861.7 22014.84 0.000000
NC/C 1 823.1 109.91 0.000000
Lipids 2 333.5 44.54 0.000000
Conc 4 478.5 63.90 0.000000
NC/C*Lipids 2 193.9 25.89 0.000000
NC/C*Conc 4 66.2 8.84 0.000011
Lipids*Conc 8 40.8 5.45 0.000036
NC/C*Lipids*Conc 8 15.6 2.08 0.052156
Error 60 7.5
Suppl. Table 4F. Statistical analysis for Fig. 4F 
(Phosphorylation in p38 kinase)
DF MS F p
Intercept 1 10.73873 790.6407 0.000000
NC/C 1 0.30803 22.6784 0.000076
Lipids 2 0.38376 28.2544 0.000000
Conc 1 0.69723 51.3333 0.000000
NC/C*Lipids 2 0.13160 9.6894 0.000823
NC/C*Conc 1 0.30803 22.6784 0.000076
Lipids*Conc 2 0.38376 28.2544 0.000000
NC/C*Lipids*Conc 2 0.13160 9.6894 0.000823
Error 24 0.01358
Suppl. Table 5. Statistical analysis for  Supp. Fig. 4 
(Incorporation of liposomes into HUVEC-ST cells)
DF MS F p
Intercept 1 0.002026 182.964 0.000000
NC/C 1 0.000518 46.774 0.000000
Lipids 2 0.000117 10.567 0.000157
Time 3 0.000060 5.400 0.002772
NC/C*Lipids 2 0.000115 10.401 0.000177
NC/C*Time 3 0.000039 3.541 0.021346
Lipids*Time 6 0.000008 0.682 0.664949
NC/C*Lipids*Time 6 0.000015 1.321 0.266076
Error 48 0.000011
